| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 148067-21-4 | ILE-THR-SER-PHE-GLU-GLU-ALA-LYS-GLY-LEU-ASP-ARG-ILE-ASN-GLU-ARG-MET-PRO-PRO-ARG-ARG-ASP-ALA-MET-PRO | ITSFEEAkgLDRINERMPPRRDAMP; CN412; ITSFEEAkgLDRINERMPPRRDAMP; H-ILE-THR-SER-PHE-GLU-GLU-ALA-LYS-GLY-LEU-ASP-ARG-ILE-ASN-GLU-ARG-MET-PRO-PRO-ARG-ARG-ASP-ALA-MET-PRO-OH; ILE-THR-SER-PHE-GLU-GLU-ALA-LYS-GLY-LEU-ASP-ARG-ILE-ASN-GLU-ARG-MET-PRO-PRO-ARG-ARG-ASP-ALA-MET-PRO; CALCINEURIN AUTOINHIBITORY FRAGMENT; CALCINEURIN AUTOINHIBITORY PEPTIDE; H-Ile-Thr-Ser-Phe-Glu-Glu-Ala-Lys-Gly-Leu-Asp-Arg-Ile-Asn-Glu-Arg-Met-Pro-Pro-Arg-Arg-Asp-Ala-Met-Pro-OH |  | C124H205N39O39S2 | 详情 | 供应商 |
| 942413-05-0 | VkgILS-NH2 |  | C28H54N8O7 | 详情 | 供应商 | |
| 475221-20-6 | AC-RIYkgVIQAIQKSDEGHPFRAYLESEVAISEELVQKYSNS-NH2; ARG-ILE-TYR-LYS-GLY-VAL-ILE-GLN-ALA-ILE-GLN-LYS-SER-ASP-GLU-GLY-HIS-PRO-PHE-ARG-ALA-TYR-LEU-GLU-SER-GLU-VAL-ALA-ILE-SER-GLU-GLU-LEU-VAL-GLN-LYS-TYR-SER-ASN-SER-NH2; AC-RIYkgVIQAIQKSDEGHPFRAYLESEVAISEELVQKYSNS-NH2; NEP1-40; NOGO-66 (1-40); NOGO-66 (1-40) ANTAGONIST PEPTIDE; NOGO EXTRACELLULAR PEPTIDE, 1-40; M.W. 4625.11 C206H324N56O65 |  | C206H324N56O65 | 详情 | 供应商 | |
| 112540-82-6 | ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA; ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA; ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-NH2: AVSEHQLLHDkgKSIQDLRRRFFLHHLIAEIHTA-NH2; ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA: AVSEHQLLHDkgKSIQDLRRRFFLHHLIAEIHTA | H-ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-OH; AVSEHQLLHDkgKSIQDLRRRFFLHHLIAEIHTA; AVSEHQLLHDkgKSIQDLRRRFFLHHLIAEIHTA-NH2; H-ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-OH; HUMORAL HYPERCALCEMIA OF MALIGNANCY FACTOR, (1-34), HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) AMIDE (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR FRAGMENT 1-34 AMIDE HUMAN | 无 | C180H287N57O48 | 详情 | 供应商 |
sitemap.xml